Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Monocyte count procedure
|
296 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Monocyte count result
|
296 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
HIV-1 infection
|
94 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.070 | 0.857 | 7 | 2002 | 2015 | ||||
Hepatitis C
|
347 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.040 | 1.000 | 4 | 2004 | 2019 | ||||
Human immunodeficiency virus (HIV) II infection category B1
|
56 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.040 | 1.000 | 4 | 2001 | 2011 | ||||
Myocardial Infarction
|
680 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.040 | 0.750 | 4 | 2001 | 2010 | ||||
Bladder Neoplasm
|
281 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.030 | 1.000 | 3 | 2010 | 2012 | ||||
Carcinoma of bladder
|
309 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.030 | 1.000 | 3 | 2010 | 2012 | ||||
Malignant neoplasm of prostate
|
1082 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.030 | 0.667 | 3 | 2012 | 2015 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.030 | 1.000 | 3 | 2010 | 2012 | ||||
Malignant Neoplasms
|
1641 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.030 | 1.000 | 3 | 2013 | 2013 | ||||
Parkinson Disease
|
990 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.030 | 0.667 | 3 | 2004 | 2019 | ||||
Primary malignant neoplasm
|
1374 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.030 | 1.000 | 3 | 2013 | 2013 | ||||
Prostate carcinoma
|
1168 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.030 | 0.667 | 3 | 2012 | 2015 | ||||
Benign Prostatic Hyperplasia
|
91 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.020 | 1.000 | 2 | 2013 | 2019 | ||||
cervical cancer
|
268 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.020 | 1.000 | 2 | 2010 | 2016 | ||||
Cervix carcinoma
|
283 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.020 | 1.000 | 2 | 2010 | 2016 | ||||
Coronary Artery Disease
|
1577 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.020 | 0.500 | 2 | 2011 | 2012 | ||||
HIV Infections
|
142 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.020 | 0.500 | 2 | 2007 | 2010 | ||||
Malignant tumor of cervix
|
245 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.020 | 1.000 | 2 | 2010 | 2016 | ||||
Multiple Sclerosis
|
1022 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.020 | 1.000 | 2 | 2010 | 2015 | ||||
Neoplasm Metastasis
|
327 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.020 | 1.000 | 2 | 2012 | 2016 | ||||
Acquired Immunodeficiency Syndrome
|
42 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||
Adrenoleukodystrophy
|
116 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Alzheimer Disease, Late Onset
|
243 | 0.572 | 0.680 | 3 | 46357717 | missense variant | G/A | snv | 0.13 | 0.12 | 0.010 | 1.000 | 1 | 2004 | 2004 |